Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer
Status:
Withdrawn
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This Phase 1, single-site, dose-escalation study is being conducted to determine the maximum
tolerated dose (MTD) of RAD001 as part of a specified combination regimen.